THE END TB STRATEGY:

progress in the Americas region

In 2022, the incidence rate increased by in the Americas region, compared to 13%
the 2015 baseline. TB deaths also increased by in the same period. 40%
End TB strategy milestones and targets
Base line Current Milestones SDG targets* END TB
Indicator situation targets
2015 2022 2020 2025 2030 2035
It should be It should be It should be
Reduction in number of TB decreased by decreased by decreased by
deaths 25 000 35 000 27 000 75% 90% 95%
6300 2500 <1300
It should be It should be It should be
Reduction in TB incidence rate decreased by decreased by decreased by
per 100 000 population 27.5 31 28.5 50% 80% 90%
13.7 5.5 <2.7
Percentage of households
facing catastrophic costs 0% NA NA 0% 0% 0%
due to TB
SDG: Sustainable Development Goals
In the region,
Number of deaths and incidence of TB
N.A: Not available.
it is estimated that

Deaths Incidence 890 cases and

In 2022, an estimated 35 000 people died, equivalent to WHO estimated a total of 325 000 cases
96 deaths from
3.4 per 100 000 population, of which 11 200 (31%) were between new and relapses in 2022, which
TB occur daily
attributed to TB/HIV cases. There was a 40% increase in represented 3% of the world total and an
deaths compared to 2015 (Fig. 1). estimated rate of 31 cases per 100 000 population. Between
2015 and 2022 there was a 13% increase in incidence (Fig. 2).

Figure 1. Estimated of deaths from tuberculosis Figure 2. Estimated tuberculosis incidence rate
40 000 Baseline 40 Baseline
38 300 25 000 27.5
36
35 000 35 000 35

30 000
31
30
Rate per 100 000 population
Number of TB deaths

27 000
25 000 25

20 000 20

15 000 15 13.5
Milestone 2025
10 000 10
6300 5.4
5 000 Milestone 2025 5 SDG 2030 2.7
2500 1300
SDG 2030
0 End TB Strategy 2035 0 End TB Strategy 2035
00 002 004 006 008 2010 2012 2014 2016 2018 020 022 024 026 028 030 032 034 00 002 004 006 008 2010 2012 2014 2016 2018 020 022 024 026 028 030 032 034
20 2 2 2 2 2 2 2 2 2 2 2 2 20 2 2 2 2 2 2 2 2 2 2 2 2
Year Year
Estimated TB deaths SDG and End TB Strategy milestones and targets Estimated TB rate trend SDG and End TB Strategy milestones and targets

Source: Global tuberculosis report 2023. WHO

 Catastrophic costs
The region is making progress in conducting national Catastrophic Cost surveys; three countries have published
the results in the WHO 2022 report, the baseline results were: Colombia 51%, Brazil 48% and El Salvador 13%.
Another 6 countries in the region are advancing in this initiative*.

100% Figure 3. Countries that completed and published their surveys results to 2022
78%
75% 65%

48% 51% All affected people with TB

50%
Only TB resistant
25%
13%

0%
Brazil Colombia El Salvador
* Catastrophic costs according to WHO are direct and indirect medical expenses, non-medical expenses and loss of income, incurred by the affected person or his/her family to face his/her illness and that
exceed 20% or more of the income received.

Priority indicators: progress in the Americas region

Indicator 2015 2022 Variation 2025
Value Value Goal

1 TB treatment coverage 81% 74% ≥ 90%

2 Percentage of new TB patients who were diagnosed by

WHO-recommended rapid tests
13% 40% ≥ 90%

Coverage of TB patients with drug susceptibility testing (DST)

3 results
36% 58% 100%

New and relapse 76% 72%

4 Treatment success rate
MDR/RR 56% 60%
≥ 90%

5 Contact tracing coverage 5% 71% ≥ 90%

children aged under 5 years 68% 58% ≥ 90%

6 TB preventive treatment coverage
HIV 30% 32% ≥ 90%

7 Percentage of TB patients who are aware of their HIV status 81% 81% 100%

8 TB case-fatality rate 7% 9% ≤ 6%

Note: 2015 should be taken as the baseline for the variation.

The End TB strategy has priority indicators that enable countries to monitor progress in its implementation, in 2022
there were variations as shown in the table above.

Source: Global tuberculosis report 2023. WHO